Patient # | Age | Sex | Eye involved | Initial thickness (mm) | AJCC tumor staging | GEP class |
---|---|---|---|---|---|---|
1 | 60 | M | R | 5.53 | T2aN0M0, stage IIA | 2 |
2 | 59 | M | R | 7.4 | T2aN0M0, stage IIA | 1 A |
3 | 67 | M | L | 4.4 | T3aN0M0, stage IIB | 2 |
4 | 65 | F | L | 3.5 | T1aN0M0, stage I | 1 A |
5 | 62 | M | L | 4.36 | T2aN0M0, stage IIA | 1B |
6 | 65 | M | R | 3.6 | T1aN0M0, stage I | 1B |
7 | 46 | M | R | 4 | T2aN0M0, stage IIA | 1B |
8 | 37 | M | R | 3.13 | T2aN0M0, stage IIA | 1A |
9 | 68 | M | L | 4.11 | T1aN0M0, stage I | 2 |
10 | 77 | F | L | 4.51 | T2aN0M0, stage IIA | 1A |
11 | 68 | F | R | 5.5 | T2aN0M0, stage IIA | 1A |
12 | 68 | F | L | 3.73 | T1aN0M0, stage I | 1A |
13 | 71 | F | R | 8.67 | T3cN0M0, stage IIIA | 2 |
14 | 73 | M | R | 3.32 | T2aN0M0, stage IIA | 2 |
15 | 66 | M | R | 3.96 | T2aN0M0, stage IIA | 1B |